세계의 맞춤형 의료 바이오인포매틱스 시장 보고서(2025년)

Personalized Medicine Bioinformatics Global Market Report 2025

US $ 4,490 ￦ 6,700,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,685,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 12,669,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

맞춤형 의료 바이오인포매틱스 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 34억 달러로 평가되었고, 2025년에는 38억 7,000만 달러에 달하고, CAGR 13.7%로 성장할 전망입니다. 역사적인 기간의 성장 원동력은 유전체 시퀀싱 기술의 채택 증가, 표적 치료에 대한 수요 증가, 바이오인포매틱스 소프트웨어 솔루션의 확대, 맞춤형 의료에서의 연구 개발의 진전, 정밀의료 이니셔티브에 대한 규제 당국의 지원입니다.

맞춤형 의료 바이오인포매틱스 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 CAGR 13.4%로 64억 달러로 성장할 전망입니다. 예측 기간 동안의 성장은 인공지능과 머신러닝 통합, 실세계 데이터 및 예측 분석 활용 확대, 클라우드 기반 바이오인포매틱스 플랫폼 확대, 건강 관리 및 기술 기업 간의 협력 관계 증가, 환자 중심 치료 접근법에 대한 관심 증가로 촉진됩니다. 예측 기간의 주요 동향으로는 예측 분석 도구 개발, 멀티오믹스 통합 혁신, 실시간 환자 모니터링 시스템 채택, 유전자 편집 기술의 발전, 환자 중심 건강 관리 모델 확대 등이 있습니다.

맞춤형 의료에 대한 수요 증가는 맞춤형 의료 바이오인포매틱스 시장의 확대를 촉진할 것으로 예측됩니다. 맞춤형 의료는 개인별 유전자 프로파일, 건강 상태, 라이프 스타일 요인에 따라 예방, 진단 및 치료를 사용자 정의합니다. 개인화된 의료의 시작은 보다 정확한 유전자 평가를 가능하게 하는 유전체 프로파일링과 데이터 분석의 진보에 의해 촉진되어 시행착오적인 접근의 필요성을 줄이면서 보다 적은 치료와 결과의 개선으로 이어집니다. 맞춤형 의료 바이오인포매틱스는 유전체과 임상 데이터를 처리하여 개별 건강 상태에 대한 통찰력을 제공하여 정확한 치료 결정 및 약물 반응 예측을 촉진합니다. 이것은 또한 개인화된 환자 관리를 강화하는 표적 치료의 사용을 유도합니다. 예를 들어, 2024년 2월 맞춤형 의료 연합(Personalized Medicine Coalition)은 FDA가 2023년 희귀질환 환자를 위한 16개의 새로운 개인화 치료를 승인했다고 보고했습니다. 이러한 맞춤형 치료의 급증은 맞춤형 의료 바이오인포매틱스 시장의 성장에 기여하고 있습니다.

맞춤형 의료 바이오인포매틱스 시장의 기업들은 질병 예측을 개선하고 환자 결과를 개선하기 위해 예측 분석 플랫폼과 같은 고급 솔루션을 개발하는 데 점점 더 주력하고 있습니다. 예측 분석 플랫폼은 머신 러닝, 알고리즘 및 통계 모델을 사용하여 과거 데이터와 실시간 데이터를 모두 분석하고, 의료 서비스 제공업체가 위험을 예측하고, 치료를 개선하고, 적극적인 의사 결정을 내릴 수 있도록 지원합니다. 예를 들어 미국의 생명공학 기업인 서티스 종양 솔루션즈는 2023년 4월 AI/ML 주도의 예측 분석 플랫폼인 CertisAI를 발표했습니다. 이 플랫폼은 빅데이터, 통계 알고리즘, 머신러닝을 활용하여 유전자 발현 바이오마커를 기반으로 약물의 효능을 예측합니다. 이 플랫폼의 목표는 의약품의 속도를 높이고 Precision On Colology에서 동반진단 약물의 개발을 지원하는 것입니다. 이 플랫폼은 현재 치료 효과를 예측하는 어프로치를 검증 중이며, 바이오 제약 기업이 조기 창약 및 개별화 암 치료에 있어서 보다 많은 정보에 근거한 의사 결정을 실시할 수 있도록, 서비스로서 제공합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 맞춤형 의료 바이오인포매틱스 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계의 맞춤형 의료 바이오인포매틱스 시장 : 성장률 분석
• 세계의 맞춤형 의료 바이오인포매틱스 시장 실적 : 규모와 성장, 2019년-2024년
• 세계의 맞춤형 의료 바이오인포매틱스 시장 예측 : 규모와 성장, 2024년-2029년, 2034년
• 세계의 맞춤형 의료 바이오인포매틱스 : 총잠재시장 규모(TAM)

제6장 시장 세분화

• 세계의 맞춤형 의료 바이오인포매틱스 시장 : 기술별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
• 유전자 시퀀싱
• 파마코유전체학
• 마이크로어레이 기술
• 인공지능 주도형 분석 플랫폼
• 기타 기술
• 세계의 맞춤형 의료 바이오인포매틱스 시장 : 용도별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
• 유전체학
• 단백질체학
• 전사체학
• 대사체학
• 에피유전체학
• 기타 용도
• 세계의 맞춤형 의료 바이오인포매틱스 시장 : 최종 사용자별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
• 생명공학과 제약회사
• 임상 진단 실험실
• 병원 및 학술 의료 센터
• 수탁연구기관 및 바이오뱅크
• 기타 최종 사용자
• 세계의 맞춤형 의료 바이오인포매틱스 시장 : 서브세그먼테이션 유전자 시퀀싱, 유형별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
• 차세대 시퀀싱(NGS)
• 산가 시퀀싱
• 1분자 실시간 시퀀싱(SMRT)
• 홀 엑솜 시퀀싱(WES)
• 전체 유전체 시퀀싱(WGS)
• 세계의 맞춤형 의료 바이오인포매틱스 시장 : 세분화 파마코유전체학, 유형별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
• 의약품과 유전자의 상호작용 해석
• 부작용(ADR) 예측
• 바이오마커 탐색
• 개인화된 약물 반응 프로파일링
• 세계의 맞춤형 의료 바이오인포매틱스 시장 : 세분화 마이크로어레이 기술, 유형별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
• 데옥시리보 핵산(DNA) 마이크로어레이
• 리보 핵산(RNA) 마이크로어레이
• 단백질 마이크로어레이
• 비교 유전체 하이브리드화(CGH) 마이크로어레이
• 세계의 맞춤형 의료 바이오인포매틱스 시장 : 세분화 인공지능 주도형 분석 플랫폼, 유형별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
• 머신러닝 기반 플랫폼
• 딥러닝 기반 플랫폼
• 자연언어처리(NLP) 플랫폼
• 예측 분석 플랫폼
• 임상 의사결정 지원 시스템(CDSS)
• 세계의 맞춤형 의료 바이오인포매틱스 시장 : 세분화 기타 기술, 유형별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
• 단백질체학 분석
• 대사체학 분석
• 에피유전체 프로파일링
• 바이오인포매틱스 클라우드 플랫폼

제7장 지역별/국가별 분석

• 세계의 맞춤형 의료 바이오인포매틱스 시장 : 지역별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
• 세계의 맞춤형 의료 바이오인포매틱스 시장 : 국가별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

• 맞춤형 의료 바이오인포매틱스 시장 : 경쟁 구도
• 맞춤형 의료 바이오인포매틱스 시장 : 기업 프로파일
  • F. Hoffmann-La Roche AG : 개요, 제품 및 서비스, 전략 및 재무 분석
  • Merck KGaA Darmstadt Germany : 개요, 제품 및 서비스, 전략 및 재무 분석
  • Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
  • Abbott Laboratories : 개요, 제품 및 서비스, 전략 및 재무 분석
  • Danaher Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

• Laboratory Corporation of America Holdings
• Quest Diagnostics Incorporated
• Agilent Technologies Inc.
• Illumina Inc.
• Bio-Rad Laboratories Inc.
• QIAGEN NV
• Myriad Genetics Inc.
• Guardant Health Inc.
• Sophia Genetics SA
• DNAnexus Inc.
• Deep Genomics Inc.
• Congenica Ltd
• Phase Genomics Inc.
• Analome Inc.
• Pluto Bioinformatics Inc.

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

• 맞춤형 의료 바이오인포매틱스 시장 2029년 : 새로운 기회를 제공하는 국가
• 맞춤형 의료 바이오인포매틱스 시장 2029년 : 새로운 기회를 제공하는 부문
• 맞춤형 의료 바이오인포매틱스 시장 2029년 : 성장 전략
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제36장 부록

SHW

영문 목차

영문목차

Personalized medicine bioinformatics refers to the application of advanced computational tools combined with biological data to analyze individual genetic and molecular profiles. It enables accurate interpretation of complex biological information to support informed medical decision making. Personalized medicine bioinformatics improves the precision of clinical insights and accelerates the identification of patient specific strategies. Its primary advantage lies in providing data driven clarity for understanding individual biological variability.

The primary technology types of personalized medicine bioinformatics include gene sequencing, pharmacogenomics, microarray technology, artificial intelligence based analytics platforms, and others. Gene sequencing determines the exact order of nucleotides in a DNA or RNA molecule to identify genetic variations that influence individual responses to drugs and therapies. It is applied in fields such as genomics, proteomics, transcriptomics, metabolomics, epigenomics, and others, and is utilized by diverse end users, including biotechnology and pharmaceutical companies, clinical diagnostic laboratories, hospitals and academic medical centers, contract research organizations, biobanks, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The personalized medicine bioinformatics market research report is one of a series of new reports from The Business Research Company that provides personalized medicine bioinformatics market statistics, including personalized medicine bioinformatics industry global market size, regional shares, competitors with a personalized medicine bioinformatics market share, detailed personalized medicine bioinformatics market segments, market trends and opportunities, and any further data you may need to thrive in the personalized medicine bioinformatics industry. The personalized medicine bioinformatics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The personalized medicine bioinformatics market size has grown rapidly in recent years. It will grow from $3.40 billion in 2024 to $3.87 billion in 2025 at a compound annual growth rate (CAGR) of 13.7%. The growth during the historic period was driven by the increasing adoption of genomic sequencing technologies, rising demand for targeted therapies, expansion of bioinformatics software solutions, progress in research and development within personalized medicine, and regulatory support for precision medicine initiatives.

The personalized medicine bioinformatics market size is expected to see rapid growth in the next few years. It will grow to $6.40 billion in 2029 at a compound annual growth rate (CAGR) of 13.4%. The growth during the forecast period is fueled by the integration of artificial intelligence and machine learning, greater use of real world data and predictive analytics, expansion of cloud based bioinformatics platforms, rising collaborations between healthcare and technology companies, and a growing focus on patient centric treatment approaches. The primary trends in the forecast period include the development of predictive analytics tools, innovations in multi omics integration, adoption of real time patient monitoring systems, advances in genome editing technologies, and the expansion of patient centric healthcare models.

The growing demand for personalized medicine is expected to drive the expansion of the personalized medicine bioinformatics market. Personalized medicine customizes prevention, diagnosis, and treatment based on an individual's unique genetic profile, health status, and lifestyle factors. The rise of personalized medicine is fueled by advancements in genomic profiling and data analytics, which enable more accurate genetic assessments, leading to more targeted treatments and improved outcomes while reducing the need for trial-and-error approaches. Personalized medicine bioinformatics processes genomic and clinical data to provide insights into individual health conditions, facilitating precise treatment decisions and predicting drug responses. This also guides the use of targeted therapies that enhance personalized patient care. For example, in February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 new personalized therapies for rare disease patients in 2023, a significant increase from just six in 2022. This surge in personalized treatments is contributing to the growth of the personalized medicine bioinformatics market.

Companies in the personalized medicine bioinformatics market are increasingly focused on developing advanced solutions such as predictive analytics platforms to improve disease prediction and enhance patient outcomes. Predictive analytics platforms use machine learning, algorithms, and statistical models to analyze both historical and real-time data, helping healthcare providers anticipate risks, refine treatments, and make proactive decisions. For instance, in April 2023, Certis Oncology Solutions, a US-based biotechnology company, introduced CertisAI, an AI/ML-driven predictive analytics platform. This platform uses big data, statistical algorithms, and machine learning to predict the efficacy of drugs based on gene expression biomarkers. Its goal is to speed up drug discovery and support the development of companion diagnostics in precision oncology. The platform is currently validating its approach to predicting therapeutic responses and is available as a service to biopharmaceutical companies to help make more informed decisions in early drug development and personalized cancer treatment.

In May 2025, GeneDx Holdings Corp., a US-based genomic testing and diagnostic services provider, acquired Fabric Genomics for up to $51 million. This acquisition aims to strengthen GeneDx's capabilities in decentralized, AI-driven genomic interpretation, speeding up the delivery of scalable and rapid genomic diagnostics. Fabric Genomics specializes in AI-powered software and services for genomic interpretation, focusing on whole genome sequencing analysis for rare diseases, hereditary risks, and cancer testing.

Major players in the personalized medicine bioinformatics market are F. Hoffmann-La Roche AG, Merck KGaA Darmstadt Germany, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Myriad Genetics Inc., Guardant Health Inc., Sophia Genetics SA, DNAnexus Inc., Deep Genomics Inc., Congenica Ltd, Phase Genomics Inc., Analome Inc., Pluto Bioinformatics Inc., BioBam Bioinformatics S.L., OncoBox Inc.

North America was the largest region in the personalized medicine bioinformatics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in personalized medicine bioinformatics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the personalized medicine bioinformatics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The personalized medicine bioinformatics market consists of revenues earned by entities by providing services next-generation sequencing (NGS), interpretation, variant annotation, and multi-omics data integration. The market value includes the value of related goods sold by the service provider or included within the service offering. The personalized medicine bioinformatics market also includes sales of genomic analysis software, variant interpretation and annotation tools, clinical decision support systems, and bioinformatics data management and workflow tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Personalized Medicine Bioinformatics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on personalized medicine bioinformatics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for personalized medicine bioinformatics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The personalized medicine bioinformatics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Technology: Gene Sequencing; Pharmacogenomics; Microarray Technology; Artificial Intelligence-Driven Analytics Platforms; Other Technologies
• 2) By Application: Genomics; Proteomics; Transcriptomics; Metabolomics; Epigenomics; Other Applications
• 3) By End-User: Biotechnology And Pharmaceutical Companies; Clinical Diagnostics Laboratories; Hospitals And Academic Medical Centers; Contract Research Organizations and Biobanks; Other End-Users
• Subsegments:
• 1) By Gene Sequencing: Next-Generation Sequencing (NGS); Sanger Sequencing; Single-Molecule Real-Time Sequencing (SMRT); Whole Exome Sequencing (WES); Whole Genome Sequencing (WGS)
• 2) By Pharmacogenomics: Drug-Gene Interaction Analysis; Adverse Drug Reaction (ADR) Prediction; Biomarker Discovery; Personalized Drug Response Profiling
• 3) By Microarray Technology: DNA Microarray; RNA Microarray; Protein Microarray; Comparative Genomic Hybridization (CGH) Microarray
• 4) By Artificial Intelligence-Driven Analytics Platforms: Machine Learning-Based Platforms; Deep Learning-Based Platforms; Natural Language Processing (NLP) Platforms; Predictive Analytics Platforms; Clinical Decision Support Systems (CDSS)
• 5) By Other Technologies: Proteomics Analysis; Metabolomics Analysis; Epigenomics Profiling; Bioinformatics Cloud Platforms
• Companies Mentioned: F. Hoffmann-La Roche AG; Merck KGaA Darmstadt Germany; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Agilent Technologies Inc.; Illumina Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Myriad Genetics Inc.; Guardant Health Inc.; Sophia Genetics SA; DNAnexus Inc.; Deep Genomics Inc.; Congenica Ltd; Phase Genomics Inc.; Analome Inc.; Pluto Bioinformatics Inc.; BioBam Bioinformatics S.L.; OncoBox Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Personalized Medicine Bioinformatics Market Characteristics

3. Personalized Medicine Bioinformatics Market Trends And Strategies

4. Personalized Medicine Bioinformatics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Personalized Medicine Bioinformatics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Personalized Medicine Bioinformatics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Personalized Medicine Bioinformatics Market Growth Rate Analysis
• 5.4. Global Personalized Medicine Bioinformatics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Personalized Medicine Bioinformatics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Personalized Medicine Bioinformatics Total Addressable Market (TAM)

6. Personalized Medicine Bioinformatics Market Segmentation

• 6.1. Global Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gene Sequencing
• Pharmacogenomics
• Microarray Technology
• Artificial Intelligence-Driven Analytics Platforms
• Other Technologies
• 6.2. Global Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genomics
• Proteomics
• Transcriptomics
• Metabolomics
• Epigenomics
• Other Applications
• 6.3. Global Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biotechnology And Pharmaceutical Companies
• Clinical Diagnostics Laboratories
• Hospitals And Academic Medical Centres
• Contact Research Organization and Biobanks
• Other End-Users
• 6.4. Global Personalized Medicine Bioinformatics Market, Sub-Segmentation Of Gene Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Next-Generation Sequencing (NGS)
• Sanger Sequencing
• Single-Molecule Real-Time Sequencing (SMRT)
• Whole Exome Sequencing (WES)
• Whole Genome Sequencing (WGS)
• 6.5. Global Personalized Medicine Bioinformatics Market, Sub-Segmentation Of Pharmacogenomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug-Gene Interaction Analysis
• Adverse Drug Reaction (ADR) Prediction
• Biomarker Discovery
• Personalized Drug Response Profiling
• 6.6. Global Personalized Medicine Bioinformatics Market, Sub-Segmentation Of Microarray Technology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Deoxyribonucleic Acid (DNA) Microarray
• Ribonucleic Acid (RNA) Microarray
• Protein Microarray
• Comparative Genomic Hybridization (CGH) Microarray
• 6.7. Global Personalized Medicine Bioinformatics Market, Sub-Segmentation Of Artificial Intelligence-Driven Analytics Platforms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Machine Learning-Based Platforms
• Deep Learning-Based Platforms
• Natural Language Processing (NLP) Platforms
• Predictive Analytics Platforms
• Clinical Decision Support Systems (CDSS)
• 6.8. Global Personalized Medicine Bioinformatics Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Proteomics Analysis
• Metabolomics Analysis
• Epigenomics Profiling
• Bioinformatics Cloud Platforms

7. Personalized Medicine Bioinformatics Market Regional And Country Analysis

• 7.1. Global Personalized Medicine Bioinformatics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Personalized Medicine Bioinformatics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Personalized Medicine Bioinformatics Market

• 8.1. Asia-Pacific Personalized Medicine Bioinformatics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Personalized Medicine Bioinformatics Market

• 9.1. China Personalized Medicine Bioinformatics Market Overview
• 9.2. China Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Personalized Medicine Bioinformatics Market

• 10.1. India Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Personalized Medicine Bioinformatics Market

• 11.1. Japan Personalized Medicine Bioinformatics Market Overview
• 11.2. Japan Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Personalized Medicine Bioinformatics Market

• 12.1. Australia Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Personalized Medicine Bioinformatics Market

• 13.1. Indonesia Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Personalized Medicine Bioinformatics Market

• 14.1. South Korea Personalized Medicine Bioinformatics Market Overview
• 14.2. South Korea Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Personalized Medicine Bioinformatics Market

• 15.1. Western Europe Personalized Medicine Bioinformatics Market Overview
• 15.2. Western Europe Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Personalized Medicine Bioinformatics Market

• 16.1. UK Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Personalized Medicine Bioinformatics Market

• 17.1. Germany Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Personalized Medicine Bioinformatics Market

• 18.1. France Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Personalized Medicine Bioinformatics Market

• 19.1. Italy Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Personalized Medicine Bioinformatics Market

• 20.1. Spain Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Personalized Medicine Bioinformatics Market

• 21.1. Eastern Europe Personalized Medicine Bioinformatics Market Overview
• 21.2. Eastern Europe Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Personalized Medicine Bioinformatics Market

• 22.1. Russia Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Personalized Medicine Bioinformatics Market

• 23.1. North America Personalized Medicine Bioinformatics Market Overview
• 23.2. North America Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Personalized Medicine Bioinformatics Market

• 24.1. USA Personalized Medicine Bioinformatics Market Overview
• 24.2. USA Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Personalized Medicine Bioinformatics Market

• 25.1. Canada Personalized Medicine Bioinformatics Market Overview
• 25.2. Canada Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Personalized Medicine Bioinformatics Market

• 26.1. South America Personalized Medicine Bioinformatics Market Overview
• 26.2. South America Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Personalized Medicine Bioinformatics Market

• 27.1. Brazil Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Personalized Medicine Bioinformatics Market

• 28.1. Middle East Personalized Medicine Bioinformatics Market Overview
• 28.2. Middle East Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Personalized Medicine Bioinformatics Market

• 29.1. Africa Personalized Medicine Bioinformatics Market Overview
• 29.2. Africa Personalized Medicine Bioinformatics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Personalized Medicine Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Personalized Medicine Bioinformatics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Personalized Medicine Bioinformatics Market Competitive Landscape And Company Profiles

• 30.1. Personalized Medicine Bioinformatics Market Competitive Landscape
• 30.2. Personalized Medicine Bioinformatics Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck KGaA Darmstadt Germany Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Personalized Medicine Bioinformatics Market Other Major And Innovative Companies

• 31.1. Laboratory Corporation of America Holdings
• 31.2. Quest Diagnostics Incorporated
• 31.3. Agilent Technologies Inc.
• 31.4. Illumina Inc.
• 31.5. Bio-Rad Laboratories Inc.
• 31.6. QIAGEN N.V.
• 31.7. Myriad Genetics Inc.
• 31.8. Guardant Health Inc.
• 31.9. Sophia Genetics SA
• 31.10. DNAnexus Inc.
• 31.11. Deep Genomics Inc.
• 31.12. Congenica Ltd
• 31.13. Phase Genomics Inc.
• 31.14. Analome Inc.
• 31.15. Pluto Bioinformatics Inc.

32. Global Personalized Medicine Bioinformatics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Personalized Medicine Bioinformatics Market

34. Recent Developments In The Personalized Medicine Bioinformatics Market

35. Personalized Medicine Bioinformatics Market High Potential Countries, Segments and Strategies

• 35.1 Personalized Medicine Bioinformatics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Personalized Medicine Bioinformatics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Personalized Medicine Bioinformatics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료